Korean J Health Promot.  2016 Jun;16(2):77-83. 10.15384/kjhp.2016.16.2.77.

Association between Physical Activity and Hypertension in Chronic Obstructive Pulmonary Disease

• Jang JH
• Ryu SD
• Kim HS
• Lee KM
• Jung SP

• KMID: 2328598
• DOI: http://doi.org/10.15384/kjhp.2016.16.2.77

Abstract

BACKGROUND
Patients with chronic obstructive pulmonary disease (COPD) have increased likelihood of hypertension, which may lead to increased mortality rates. This study investigated the incidence of hypertension in patients with COPD according to the levels of their physical activities.
METHODS
This study used data from the fifth Korean National Health and Nutrition Examination Survey, conducted from 2010 to 2012, including 1,243 people aged 40 years or older with COPD who were cross-classified according to their levels of physical activity. The relevance of morbidity associated with high blood pressure was also evaluated through cross and logistic regression analyses.
RESULTS
Among patients with COPD who performed moderate-intensity physical activities, the group without hypertension had 4.3% higher compared to the group with hypertension (P=0.012). Adjusted analysis for patient age, sex, body mass index, smoking, drinking habit, income, diabetes mellitus, hyperlipidemia, and energy intake performed to determine the relationship between physical activity level and hypertension revealed that patients with moderate-intensity physical activity had 53.6% lower (95% confidence interval: 0.288-0.997) incidence of hypertension.
CONCLUSIONS
The results of the current study suggest that patients with COPD who perform moderate-intensity physical activity have a lower incidence of hypertension.

Keyword

Chronic obstructive pulmonary disease; Hypertension; Physical activity

MeSH Terms

Body Mass Index
Diabetes Mellitus
Drinking
Energy Intake
Humans
Hyperlipidemias
Hypertension*
Incidence
Logistic Models
Mortality
Motor Activity*
Nutrition Surveys
Pulmonary Disease, Chronic Obstructive*
Smoke
Smoking
Smoke

Reference

References

1. Moon HS. Guideline of COPD. Reston: Korean Academy of Tuberculosis and Respiratory Diseases;2012. [Accessed July 15, 2015].http://www.lungkorea.org/thesis/guide.php.

2. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006; 27(2):397–412.

3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3(11):): e442.

4. Bousquet J, Kiley J, Bateman ED, Viegi G, Cruz AA, Khaltaev N, et al. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J. 2010; 36(5):995–1001.

5. Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology. 2011; 16(4):659–65.

6. Maclay JD, McAllister DA, Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology. 2007; 12(5):): 634 –41.

7. Korea Centers for Disease Control and Prevention. The Third Korea National health statistics National Health and Nutrition Examination Survey (KNHANS IV). Seoul: Korea Centers for Disease Control and Prevention;2011. p. 1–727.

8. World Health Organization. A global brief on Hypertension. Geneva: World Health Organization;2013. [Accessed August 1, 2015].http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension.pdf.

9. Padwal R, Straus SE, McAlister FA. Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review. BMJ. 2001; 322(7292):977–80.

10. Antonelli-Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, et al. Comorbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J. 1997; 10(12):2794–800.

11. Jo YS, Choi SM, Lee J, Park YS, Lee SM, Yim JJ, el al. The relationship between chronic obstructive pulmonary disease and comorbidities: a cross-sectional study using data from KNH-ANES 2010–2012. Respir Med. 2015; 109(1):96–104.

12. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008; 32(4):962–9.

13. Bento VF, Albino FB, Moura KF, Maftum GJ, Santos Mde C, Guarita-Souza LC, et al. Impact of physical activity interventions on blood pressure in Brazilian populations. Arq Bras Cardiol. 2015; 105(3):301–8.

14. Fagard RH. Exercise characteristics and the blood pressure response to dynamic physical training. Med Sci Sports Exerc. 2001; 33(6 Suppl):): S484–92; discussion. S493–4.

15. Padillla J, Wallace JP, Park S. Accumulation of physical activity reduces blood pressure in pre- and hypertension. Med Sci Sports Exerc. 2005; 37(8):1264–75.

16. IPAQ research committee. Guideline for data processing and analysis of the international physical activity questionnaire (IPAQ) – Short and long forms, Revised Nov 2005. Place unknown: IPAQ research committee;. 2010. [Accessed July 30, 2015].https://sites.google.com/site/theipaq/scoring-protocol.

17. Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis. 2009; 4:337–49.

18. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005; 128(4):2640–6.